Supernus Pharmaceuticals

Supernus’ depression drug improved symptoms in two hours in Phase IIa study
Clinical Trials Arena
Sun, 10/20/24 - 10:24 pm
Supernus Pharmaceuticals
SPN-820
major depressive disorder
clinical trials
Supernus links depression drug to fast responses in phase 2 trial
Fierce Biotech
Fri, 10/18/24 - 10:18 am
Supernus Pharmaceuticals
major depressive disorder
SPN-820
US consumer group seeks stronger warnings on Botox, similar treatments
Reuters
Tue, 12/12/23 - 10:02 am
Public Citizen
FDA
Botox
AbbVie
Revance Therapeutics
Daxxify
Evolus
Jeuveau
Supernus Pharmaceuticals
Myobloc
Galderma
Dysport
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
Tue, 03/21/23 - 09:56 pm
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents
Working its way through a CRL on lead drug, Supernus taps $150M loan
Endpoints
Wed, 02/15/23 - 06:17 pm
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
Endpoints
Mon, 10/10/22 - 06:47 pm
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
FDA approves expanded indication for Supernus’ Qelbree for ADHD
Pharmaceutical Business Review
Mon, 05/2/22 - 10:59 am
Supernus Pharmaceuticals
Qelbree
ADHD
FDA
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Fierce Pharma
Wed, 04/7/21 - 10:21 am
Supernus Pharmaceuticals
Qelbree
ADHD
drug launches
FDA Approves Novel Non-Stimulant Treatment for ADHD
BioSpace
Mon, 04/5/21 - 02:38 pm
Supernus Pharmaceuticals
ADHD
FDA
pediatric
Qelbree
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs
Xconomy
Wed, 04/29/20 - 10:43 pm
Supernus Pharmaceuticals
US WorldMeds
Supernus Pharmaceuticals seeks FDA approval for ADHD drug
Bizjournals
Tue, 11/12/19 - 07:52 pm
ADHD
FDA
Supernus Pharmaceuticals
SPN-812
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sun, 03/24/19 - 12:02 pm
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
Endpoints
Thu, 12/20/18 - 10:10 am
Supernus Pharmaceuticals
ADHD
clinical trials
SPN-812
Why Supernus Pharmaceuticals Inc. Is Having a Rather Non-Super Day
Motley Fool
Tue, 11/7/17 - 09:34 pm
Supernus Pharmaceuticals
earnings
Supernus Pharma Tanks on Settlement of Two Patent Disputes
Investopedia
Wed, 03/8/17 - 09:52 am
Supernus Pharmaceuticals
patents
Actavis
Teva Pharmaceutical
Trokendi XR
5 Biotech Stocks Under $10 on the Move
TheStreet.com
Fri, 09/20/13 - 12:34 pm
biotech
Organovo
Supernus Pharmaceuticals
ARCA biopharma
Cerus
Transition Therapeutics
This Week in Biotech
Motley Fool
Sun, 08/25/13 - 11:27 am
Supernus Pharmaceuticals
Novartis
Pain Therapeutics
GTx
Supernus Launches Oxtellar XR in the United States
Review Seeker
Sun, 02/3/13 - 11:40 am
Supernus Pharmaceuticals
Oxtellar XR
epilepsy
Favorable AcelRx Stock Offering Price May Catalyze The Company's Share Price
Seeking Alpha
Fri, 12/7/12 - 10:37 am
AcelRx
Supernus Pharmaceuticals
Do Oxtellar and Trokendi Make Supernus a Buy?
Motley Fool
Wed, 12/5/12 - 12:06 pm
Oxtellar
Trokendi
Supernus Pharmaceuticals
JNJ
Novartis

Pages